Nausea and vomiting during high-dose interleukin-2 (HD IL-2) therapy.

被引：0
|
作者：
Fesler, Mark
Chu, Melinda Bernabe
Armbrecht, Eric
Fosko, Scott
Hsueh, Eddy C.
Richart, John M.
机构：
[1] St Louis Univ, St Louis, MO 63103 USA
[2] St Louis Univ, Ctr Outcomes Res, St Louis, MO 63103 USA
[3] St Louis Univ, Dept Dermatol, St Louis, MO 63103 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20661
引用
收藏
页数：1
相关论文
共 50 条
  • [41] INTERLEUKIN-2 (IL-2) AND ITS RECEPTOR
    LARSSON, EL
    MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1986, 3 (3-4): : 231 - 236
  • [42] PHOSPHORYLATION OF HUMAN INTERLEUKIN-2 (IL-2)
    KUNG, HF
    CALVERT, I
    BEKESI, E
    KHAN, FR
    HUANG, KP
    OROSZLAN, S
    HENDERSON, LE
    COPELAND, TD
    SOWDER, RC
    WEI, SJ
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1989, 89 (01) : 29 - 35
  • [43] INTERLEUKIN-2 (IL-2) AUGMENTS TRANSCRIPTION OF THE IL-2 RECEPTOR GENE
    DEPPER, JM
    LEONARD, WJ
    DROGULA, C
    KRONKE, M
    WALDMANN, TA
    GREENE, WC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (12) : 4230 - 4234
  • [44] PROGRESSIVE VASODILATION AND THORACIC FLUID ACCUMULATION DURING RECOMBINANT INTERLEUKIN-2 (IL-2) THERAPY
    TEXTOR, SC
    MARGOLIN, K
    VENKATARAMAN, K
    HORAK, D
    DOROSHOW, J
    CLINICAL RESEARCH, 1989, 37 (02): : A471 - A471
  • [45] INTERLEUKIN-2 (IL-2) ASSAYS COMPARED BY MEASURING BOVINE IL-2
    SPLITTER, GA
    MILLEREDGE, M
    FEDERATION PROCEEDINGS, 1983, 42 (03) : 447 - 447
  • [46] PROGRESSIVE VASODILATION AND THORACIC FLUID ACCUMULATION DURING RECOMBINANT INTERLEUKIN-2 (IL-2) THERAPY
    TEXTOR, SC
    MARGOLIN, K
    VENKATARAMAN, K
    HORAK, D
    DOROSHOW, J
    CLINICAL RESEARCH, 1989, 37 (01): : A144 - A144
  • [47] High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
    Silk, Ann W.
    Kaufman, Howard L.
    Curti, Brendan
    Mehnert, Janice M.
    Margolin, Kim
    McDermott, David
    Clark, Joseph
    Newman, Jenna
    Bommareddy, Praveen K.
    Denzin, Lisa
    Najmi, Saltanat
    Haider, Azra
    Shih, Weichung
    Kane, Michael P.
    Zloza, Andrew
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [48] The Proclaimsm (Proleukin® Observational Study to Evaluate Treatment Patterns and Clinical Response in Malignancy) Study: The Response Rates for High Dose Interleukin-2 (HD IL-2) Therapy
    Kaufman, Howard
    McDermott, David
    Morse, Michael
    Lowder, James
    Wong, Michael
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (09) : 749 - 750
  • [49] Immune checkpoint inhibitors (ICI) in clear cell renal cell carcinoma (ccRCC) following high-dose interleukin-2 (IL-2)
    Elias, Roy
    Bowman, Isaac Alexander
    Hammers, Hans J.
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [50] INTERLEUKIN-2 (IL-2) AND INTERLEUKIN-2 RECEPTOR (IL-2-R) IN PULMONARY TUBERCULOSIS (TB)
    YAO, Y
    DAI, C
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A218 - A218
12345